{"product_id":"triple-regulator-10mg","title":"Triple Regulator (10mg)","description":"\u003cdiv\u003e\n\u003cdiv class=\"group  relative pb-3\"\u003e\n\u003cdiv class=\"font-claude-response  relative  leading-[1.65rem]  [\u0026amp;_pre\u0026gt;div]:bg-bg-000\/50  [\u0026amp;_pre\u0026gt;div]:border-0.5  [\u0026amp;_pre\u0026gt;div]:border-border-400  [\u0026amp;_.ignore-pre-bg\u0026gt;div]:bg-transparent  [\u0026amp;_.standard-markdown_:is(p,blockquote,h1,h2,h3,h4,h5,h6)]:pl-2  [\u0026amp;_.standard-markdown_:is(p,blockquote,ul,ol,h1,h2,h3,h4,h5,h6)]:pr-8  [\u0026amp;_.progressive-markdown_:is(p,blockquote,h1,h2,h3,h4,h5,h6)]:pl-2  [\u0026amp;_.progressive-markdown_:is(p,blockquote,ul,ol,h1,h2,h3,h4,h5,h6)]:pr-8\"\u003e\n\u003cdiv class=\"grid-cols-1 grid gap-2.5 [\u0026amp;_\u0026gt;_*]:min-w-0 standard-markdown\"\u003e\n\u003ch2\u003e\n\u003cmeta charset=\"utf-8\"\u003e \u003cspan\u003eTriple Regulator (10mg)\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003ch2\u003e\u003cspan\u003eOverview\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eTriple Regulator\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e is a synthetic \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003etriple-receptor agonist peptide\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e designed to simultaneously activate the \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucagon-like peptide-1 (GLP-1) receptor\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucose-dependent insulinotropic polypeptide (GIP) receptor\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucagon receptor (GCGR)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. This unique three-pathway mechanism has made it one of the most extensively studied investigational peptides in contemporary metabolic research. Unlike first-generation GLP-1 receptor agonists or dual GLP-1\/GIP agonists, Triple Regulator™ incorporates glucagon receptor signaling to investigate the combined effects of appetite regulation, glucose homeostasis, and energy expenditure within a single molecular framework.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eIn preclinical and clinical research, Triple Regulator has been investigated as a model compound for studying \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ewhole-body metabolic regulation\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ebody composition\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ehepatic lipid metabolism\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eenergy balance\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003emulti-receptor endocrine signaling\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Its balanced pharmacology provides researchers with a valuable platform for exploring how coordinated activation of multiple metabolic pathways influences physiological adaptation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eContent note:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e \"10 mg\" refers to \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eresearch vial content\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, not dosing guidance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch2\u003e\u003cspan\u003eChemical Structure\u003c\/span\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eClass:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Triple incretin receptor agonist peptide\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eReceptor Targets:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR)\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eResearch Identifier:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e LY3437943 \u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003ePeptide Type:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Synthetic modified peptide\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eMechanism:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Balanced triple receptor agonism\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cspan\u003eSynonyms:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e LY3437943, Triple GLP Agonist\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch2\u003e\u003cspan\u003eResearch Applications \u0026amp; Findings\u003c\/span\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cspan\u003e1. Triple-Receptor Metabolic Signaling\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTriple Regulator is primarily investigated for its ability to simultaneously activate \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eGLP-1, GIP, and glucagon receptors\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, allowing researchers to examine how coordinated incretin and glucagon signaling influences metabolic regulation. This integrated receptor profile distinguishes it from earlier single- and dual-receptor agonists and has made it a leading model for studying multi-pathway endocrine physiology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cspan\u003e2. Energy Expenditure and Body Composition Research\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eA defining feature of Triple Regulator is the addition of \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucagon receptor activation\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, which is being investigated for its influence on \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eenergy expenditure\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003efat oxidation\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ewhole-body metabolic rate\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Experimental models evaluate how this pathway interacts with GLP-1 and GIP signaling to influence body composition and substrate utilization beyond appetite-related mechanisms alone.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cspan\u003e3. Glucose Homeostasis and Endocrine Physiology\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTriple Regulator is widely used in metabolic research examining \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucose regulation\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003einsulin secretion\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eendocrine signaling\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Investigators study how simultaneous receptor activation affects pancreatic hormone dynamics, glucose handling, and systemic metabolic coordination across multiple tissues.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cspan\u003e4. Hepatic and Lipid Metabolism Models\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eResearch has explored Triple Regulator in models of \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ehepatic lipid metabolism\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003efatty liver biology\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003elipid utilization\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Studies investigate how combined incretin and glucagon receptor activity influences liver fat accumulation, fatty acid oxidation, and broader metabolic adaptations involved in energy balance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cspan\u003e5. Next-Generation Multi-Agonist Research\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTriple Regulator serves as a reference molecule for investigating the emerging field of \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003emulti-agonist peptide therapeutics\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e. Researchers use it to compare the biological effects of triple receptor activation against single- and dual-agonist compounds while exploring receptor synergy, signaling efficiency, and downstream metabolic pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003ch2\u003e\u003cspan\u003eResearch Status\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eTriple Regulator is an \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003einvestigational research peptide\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e that remains under active clinical and preclinical evaluation. It has attracted significant scientific interest because of its novel \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003etriple-receptor agonist mechanism\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, making it one of the most advanced compounds for studying integrated metabolic signaling. Although published research continues to expand, the molecule remains investigational and continues to be evaluated across multiple research programs exploring obesity, metabolic disease, and related endocrine pathways.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Elevated Vitality Peptides","offers":[{"title":"Default Title","offer_id":48130995978292,"sku":"RT-10","price":149.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9716\/8436\/files\/TripleRegulator_10mg.png?v=1786405413","url":"https:\/\/elevatedvitalitypeptides.com\/products\/triple-regulator-10mg","provider":"Elevated Vitality Peptides","version":"1.0","type":"link"}